To convert the meeting times to your local time Click Here
Industry Hall 1
The management of patients with platinum-resistant ovarian cancer continues to be extremely challenging. The purpose of this symposium is to review and discuss current treatment options and future opportunities with an expert panel. The agenda will be divided into three sections: 1) comparing existing studies in PROC, 2) review of recent findings and ongoing studies using novel therapeutic strategies, and 3) discussing the definition of PROC, novel trial designs, and biomarkers to enhance patient identification and treatment allocation.